Gastroenterology

Gastroenterology

Volume 133, Issue 2, August 2007, Pages 403-411
Gastroenterology

Clinical–alimentary tract
Central Adiposity and Risk of Barrett’s Esophagus

https://doi.org/10.1053/j.gastro.2007.05.026Get rights and content

Background & Aims: Aside from chronic reflux, the etiology of Barrett’s esophagus (BE) remains largely unknown. This case-control study investigated body mass index (BMI), central adiposity, and cigarette smoking and risk of BE. Methods: Washington residents newly diagnosed with specialized intestinal metaplasia on at least 1 of 4 esophageal biopsy specimens taken at community gastroenterology clinics (cases [n = 193]) were compared with matched population controls (n = 211). Case subgroups included those with any visible columnar epithelium (visible BE) and those with at least 2 cm of columnar epithelium (long-segment BE [LSBE]). Interviewers conducted personal interviews and took anthropometric measurements. Results: All measures of central adiposity were strongly related to BE risk, particularly for LSBE. For the high category of waist-to-hip ratio (WHR), the adjusted odds ratios were 2.4 (95% confidence interval [CI]: 1.4–3.9) for all cases, 2.8 (95% CI: 1.5–5.1) for visible BE, and 4.3 (95% CI: 1.9–9.9) for LSBE. In contrast, the associations with BMI were weaker. When BMI and WHR were modeled simultaneously, the associations with BMI were greatly attenuated, whereas those with WHR remained strong. Further adjustment for frequency of heartburn did not change these results. Cigarette smoking moderately increased risk but with no evidence of a dose-dependent response or increasing strength by case group. Conclusions: These observations indicate the importance of identifying the mechanisms underlying obesity’s role in BE and esophageal adenocarcinoma, and suggest that weight loss might be a fruitful approach to the prevention of these diseases.

Section snippets

Study Participants

Case participants were selected from among western Washington residents aged 20–80 years without previously diagnosed BE who underwent an upper endoscopy for the investigation of refractory GERD symptoms at 1 of 4 community gastroenterology clinics between October 1, 1997, and September 30, 2000. Potential participants were recruited in conjunction with their endoscopy visit. Those consenting had 4-quadrant biopsy specimens taken from the tubular esophagus just distal to the squamocolumnar

Results

Table 1 presents selected sociodemographic characteristics of cases and controls. Age, gender, race, and Hispanic origin were similarly distributed. There was a slightly higher percentage of college-educated controls, as well as a higher percentage of controls in the highest income bracket. Of 197 cases with SIM, 97 were VBE cases, and, of those VBE cases, 54 were cases of LSBE.

The association between the 3 cases groups (SIM, VBE, and LSBE) and the various measures of adiposity are presented in

Discussion

In this case-control study, we observed that measures of central adiposity, including WHR, WTR, and WC, were strong and significant risk factors for BE after taking into account the potential confounding effects of age, gender, education, race, alcohol consumption, and cigarette smoking history. Additional adjustment for the effects of BMI had minimal effects on the strength of the associations between BE and measures of central obesity. In contrast, the association between risk of BE and BMI

References (61)

  • P. Somasundar et al.

    Leptin is a growth factor in cancer

    J Surg Res

    (2004)
  • Y. Wang et al.

    Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner

    J Biol Chem

    (2005)
  • A. Koerner et al.

    Adipocytokines: leptin—the classical, resistin—the controversial, adiponectin—the promising, and more to come

    Best Pract Res Clin Endocrinol Metab

    (2005)
  • M. Otero et al.

    Leptin, from fat to inflammation: old questions and new insights

    FEBS Lett

    (2005)
  • A.J. Cameron et al.

    Prevalence of columnar-lined (Barrett’s) esophagusComparison of population-based clinical and autopsy findings

    Gastroenterology

    (1990)
  • S.S. Devesa et al.

    Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

    Cancer

    (1998)
  • J. Jeon et al.

    Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States)

    Cancer Causes Control

    (2006)
  • H. Pohl et al.

    The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence

    J Natl Cancer Inst

    (2005)
  • J. Lagergren et al.

    Association between body mass and adenocarcinoma of the esophagus and gastric cardia

    Ann Intern Med

    (1999)
  • C. Samanic et al.

    Relation of body mass index to cancer risk in 362,552 Swedish men

    Cancer Causes Control

    (2006)
  • R.J. MacInnis et al.

    Body size and composition and the risk of gastric and oesophageal adenocarcinoma

    Int J Cancer

    (2006)
  • H. Hampel et al.

    Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications

    Ann Intern Med

    (2005)
  • W.H. Chow et al.

    Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia

    J Natl Cancer Inst

    (1998)
  • B.C. Jacobson et al.

    Body-mass index and symptoms of gastroesophageal reflux in women

    N Engl J Med

    (2006)
  • L. Murray et al.

    Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project

    Int J Epidemiol

    (2003)
  • M. Nilsson et al.

    Obesity and estrogen as risk factors for gastroesophageal reflux symptoms

    JAMA

    (2003)
  • D.J. Stein et al.

    The association of body mass index with Barrett’s oesophagus

    Aliment Pharmacol Ther

    (2005)
  • K.J. Smith et al.

    Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus

    Cancer Epidemiol Biomarkers Prev

    (2005)
  • H.B. El-Serag et al.

    Abdominal obesity and the risk of Barrett’s esophagus

    Am J Gastroenterol

    (2005)
  • T.L. Vaughan et al.

    Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett’s esophagus

    Cancer Epidemiol Biomarkers Prev

    (2002)
  • Cited by (261)

    • Obesity and impact on gastroesophageal reflux disease

      2022, Obesity and Esophageal Disorders
    • Complications of bariatric surgery in adolescents

      2020, Seminars in Pediatric Surgery
    View all citing articles on Scopus

    Supported by US National Institutes of Health (grant number R01 CA72866) and P01 CA091955.

    Conflicts of interest: None.

    View full text